BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 10886240)

  • 21. STAT1-independent down-regulation of interferon-gamma-induced class II transactivator and HLA-DR expression by transforming growth factor beta-1 in human glomerular endothelial cells.
    Yang WS; Han NJ; Kim CS; Ahn H; Lee SK; Lee KU; Park SK
    Nephron Exp Nephrol; 2005; 100(3):e124-31. PubMed ID: 15824515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression.
    Murphy SP; Tomasi TB
    Mol Reprod Dev; 1998 Sep; 51(1):1-12. PubMed ID: 9712312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
    Rohn W; Tang LP; Dong Y; Benveniste EN
    J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of human anti-porcine T-cell immune responses by major histocompatibility complex class II transactivator constructs lacking the amino terminal domain.
    Yun S; Gustafsson K; Fabre JW
    Transplantation; 1998 Jul; 66(1):103-11. PubMed ID: 9679829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Class II transactivator-independent endothelial cell MHC class II gene activation induced by lymphocyte adhesion.
    Collinge M; Pardi R; Bender JR
    J Immunol; 1998 Aug; 161(4):1589-93. PubMed ID: 9712019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction.
    Chin KC; Mao C; Skinner C; Riley JL; Wright KL; Moreno CS; Stark GR; Boss JM; Ting JP
    Immunity; 1994 Nov; 1(8):687-97. PubMed ID: 7600294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged MHC class II expression and CIITA transcription in human keratinocytes.
    Takagi A; Nishiyama C; Kanada S; Niwa Y; Fukuyama K; Ikeda S; Okumura K; Ogawa H
    Biochem Biophys Res Commun; 2006 Aug; 347(2):388-93. PubMed ID: 16836979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potentiation by thyroid hormone of human IFN-gamma-induced HLA-DR expression.
    Lin HY; Martino LJ; Wilcox BD; Davis FB; Gordinier JK; Davis PJ
    J Immunol; 1998 Jul; 161(2):843-9. PubMed ID: 9670962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of major histocompatibility class II protein expression by varicella-zoster virus.
    Abendroth A; Slobedman B; Lee E; Mellins E; Wallace M; Arvin AM
    J Virol; 2000 Feb; 74(4):1900-7. PubMed ID: 10644363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells.
    Berrih S; Arenzana-Seisdedos F; Cohen S; Devos R; Charron D; Virelizier JL
    J Immunol; 1985 Aug; 135(2):1165-71. PubMed ID: 3925000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGF-beta attenuates the class II transactivator and reveals an accessory pathway of IFN-gamma action.
    Nandan D; Reiner NE
    J Immunol; 1997 Feb; 158(3):1095-101. PubMed ID: 9013947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma.
    Piskurich JF; Gilbert CA; Ashley BD; Zhao M; Chen H; Wu J; Bolick SC; Wright KL
    Mol Immunol; 2006 Feb; 43(6):519-28. PubMed ID: 15950283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain.
    Itoh-Lindstrom Y; Piskurich JF; Felix NJ; Wang Y; Brickey WJ; Platt JL; Koller BH; Ting JP
    J Immunol; 1999 Sep; 163(5):2425-31. PubMed ID: 10452977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression.
    Chang CH; Guerder S; Hong SC; van Ewijk W; Flavell RA
    Immunity; 1996 Feb; 4(2):167-78. PubMed ID: 8624807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human parainfluenza virus type 3 inhibits gamma interferon-induced major histocompatibility complex class II expression directly and by inducing alpha/beta interferon.
    Gao J; De BP; Han Y; Choudhary S; Ransohoff R; Banerjee AK
    J Virol; 2001 Feb; 75(3):1124-31. PubMed ID: 11152485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA in IFN-gamma-inducible MHC-II gene expression.
    Zika E; Fauquier L; Vandel L; Ting JP
    Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16321-6. PubMed ID: 16254053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.
    Sartoris S; Valle MT; Barbaro AL; Tosi G; Cestari T; D'Agostino A; Megiovanni AM; Manca F; Accolla RS
    J Immunol; 1998 Jul; 161(2):814-20. PubMed ID: 9670958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Constitutive expression of MHC class II genes in melanoma cell lines results from the transcription of class II transactivator abnormally initiated from its B cell-specific promoter.
    Deffrennes V; Vedrenne J; Stolzenberg MC; Piskurich J; Barbieri G; Ting JP; Charron D; Alcaïde-Loridan C
    J Immunol; 2001 Jul; 167(1):98-106. PubMed ID: 11418637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CIITA activates the expression of MHC class II genes in mouse T cells.
    Chang CH; Hong SC; Hughes CC; Janeway CA; Flavell RA
    Int Immunol; 1995 Sep; 7(9):1515-8. PubMed ID: 7495759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.